Keheala Selected to Attend the TechEmerge Health Innovation Summit in Brazil

Keheala selected by World Bank Group and Brazilian healthcare providers for piloting opportunity.

Keheala Announces Investment by Check Point Software Technologies Co-Founder, Marius Nacht

Improved Diagnostics Fail to Halt the Rise of Tuberculosis

Medical Devices, Leadership, Innovation, Evidence, Development Financing, Drug ResistanceJon RathauserNovember 18, 2017diagnostics, tb, Development Financing, Social Interventions

USAID Announces Keheala Amongst Recipients of Development Innovation Ventures Grant

The U.S. Agency for International Development (USAID) through the Global Development Lab's Development Innovation Ventures (DIV) program announced Keheala as one of 18 recent grantees. While the majority of grantees are new to USAID, this is the second award Keheala has received from the development agency to improve tuberculosis treatment success rates in Kenya.